XBiotech Inc.

XBiotech Inc. (ticker: XBIT) is an NASDAQ-listed pharmaceutical preparations company. DredgeCap's structured extraction of XBIT's SEC filings surfaces 1 active risk signal, including 1 auditor-change signal. XBIT reported no tagged revenue in revenue and -$5.50M for the period ending 2026-03-31, with operating cash flow of -$8.97M. Cash and equivalents stood at $115.46M (down 25.9% year-over-year). Total assets of $139.84M exceed total liabilities of $4.82M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.

XBIT Risk Flags

Consolidated view of every risk_flag row XBIThas surfaced across DredgeCap's extractor pipeline (auditor changes, late filings, delistings, going-concern, dilution, etc.). Each row carries a verbatim source_excerpt and links to the source SEC filing on EDGAR.

Category	Severity	Source	Excerpt	EDGAR
Auditor Change	low	10-K/A · May 1, 2024	PCAOB-tagged auditor in 10-K/A filed 2024-05-01 (accession 0001193125-24-127331) was 'Whitley Pann LLP' (PCAOB Firm ID: 726). Prior 10-K filed 2023-03-15 (accession 0001171843-23-001705) was 'Ernst & Young LLP' (PCAOB Firm ID: 42).	view ↗

Related on XBIT

Auditor & opinion →

Source for auditor_change + going-concern flags.

Share-count dilution →

Source for dilution + convertible-debt flags.

Risk-flag rows are produced by DredgeCap's extractor pipeline (lib/extract-auditor-changes, extract-late-filings, etc.). Each row carries a verbatim source_excerpt from the underlying SEC filing — no AI-generated language. Refresh runs daily. Not financial advice.